July 14 (Reuters) - The U.S. drugmaker Wyeth said on Tuesday that the Ministry of Health of Chile was the first state agency to approve its Prevenar Vaccine 13, aimed at children between six weeks and five years to prevent invasive pneumococcal disease, pneumonia and otitis media.
SC IB /
0 comments:
Post a Comment